VENBIO PARTNERS LLC Holdings

VENBIO PARTNERS LLC is an investment fund managing more than 432.23M US dollars. The largest holdings include Ventyx Biosciences, ALX Oncology Holdings and CinCor Pharma. In Q2 2022 the fund bought assets of total value of 5.67M US dollars and sold assets of total value of 646K US dollars.

$432.23M

portfolio value

+45.53%

quarter

-53.65%

1 year

-106.62%

3 years

VENBIO PARTNERS LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2019	76559000	6148000
Q2 2019	130285000	4419000
Q3 2020	558397000	19391000
Q1 2021	64447000	41000
Q2 2021	59817000	11349000
Q4 2021	99529000	14310000
Q1 2022	34742000	41712000
Q2 2022	5670000	646000

VENBIO PARTNERS LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 40.48% Portfolio value: 174.95M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q4 2021	share	40.48%	174.95M	N/A	$28.09	N/A	N/A Q4 2021
Biotechnology ALX Oncology Holdings Inc. Portfolio share: 21.48% Portfolio value: 92.82M Avg. open price: N/A Current price: $11.92 P/L: N/A N/A Q3 2020	share	21.48%	92.82M	N/A	$11.92	N/A	N/A Q3 2020
Biotechnology CinCor Pharma, Inc. Portfolio share: 14.14% Portfolio value: 61.11M Avg. open price: $17.54 Current price: $12.33 P/L: -29.70% Sold -13.18% shares Q3 2022	share	14.14%	61.11M	$17.54	$12.33	-29.70%	Sold -13.18% shares Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 11.53% Portfolio value: 49.85M Avg. open price: N/A Current price: $60.91 P/L: N/A Sold -22.30% shares Q3 2022	share	11.53%	49.85M	N/A	$60.91	N/A	Sold -22.30% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 4.70% Portfolio value: 20.31M Avg. open price: N/A Current price: $44.04 P/L: N/A Sold -72.53% shares Q3 2022	share	4.70%	20.31M	N/A	$44.04	N/A	Sold -72.53% shares Q3 2022
Biotechnology Pharvaris N.V. Portfolio share: 4.08% Portfolio value: 17.61M Avg. open price: N/A Current price: $2.02 P/L: N/A Sold -0.21% shares Q3 2022	share	4.08%	17.61M	N/A	$2.02	N/A	Sold -0.21% shares Q3 2022
Biotechnology Impel Pharmaceuticals Inc. Portfolio share: 3.11% Portfolio value: 13.44M Avg. open price: N/A Current price: $2.9 P/L: N/A N/A Q2 2021	share	3.11%	13.44M	N/A	$2.9	N/A	N/A Q2 2021
Biotechnology Elevation Oncology, Inc. Portfolio share: 0.49% Portfolio value: 2.10M Avg. open price: N/A Current price: $0.95 P/L: N/A Sold -28.44% shares Q2 2022	share	0.49%	2.10M	N/A	$0.95	N/A	Sold -28.44% shares Q2 2022
Biotechnology Verona Pharma plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $13.57 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$13.57	N/A	Sold -100.00% shares Q3 2022

Showing TOP 9 VENBIO PARTNERS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of VENBIO PARTNERS LLC?

The biggest position of the VENBIO PARTNERS LLC is Ventyx Biosciences, Inc. (VTYX) with 40.48% portfolio share worth of 174.95M US dollars.

Top 5 VENBIO PARTNERS's holdings represent 92.33% of the portfolio:

Ventyx Biosciences, Inc. (VTYX) – 40.48%
ALX Oncology Holdings Inc. (ALXO) – 21.48%
CinCor Pharma, Inc. (CINC) – 14.14%
Harmony Biosciences Holdings, Inc. (HRMY) – 11.53%
Akero Therapeutics, Inc. (AKRO) – 4.7%

Who is the portfolio manager of VENBIO PARTNERS LLC?

The portfolio manager of the VENBIO PARTNERS LLC is .

What is the total asset value of the VENBIO PARTNERS LLC portfolio?

VENBIO PARTNERS LLC total asset value (portfolio value) is 432.23M US dollars.

Who is ?

is the portfolio manager of the VENBIO PARTNERS LLC.

What is (VENBIO PARTNERS LLC) fund performance?

VENBIO PARTNERS's quarterly performance is +45.53%, annualy -53.65%. In the past 3 years, the value of 's portfolio has decreased by -107%.

What is the VENBIO PARTNERS LLC CIK?

VENBIO PARTNERS's Central Index Key is 0001776382 .